Sponsor or institution
Clinical trials and research at Australasian Gastro-Intestinal Trials Group
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Australasian Gastro-Intestinal Trials Group that are recruiting, at sites in 3 countries (most in Australia (4), Canada (1), New Zealand (1)). By phase: Phase 2 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| MRI-guided adaptive stereotactic radiotherapy for abdominal cancer | — | Darlinghurst, New South Wales and 1 other locations | Recruiting | Sep 19, 2024 |
| Combining Durvalumab and Olaparib for Advanced Cholangiocarcinoma Treatment | Phase 2 | Camperdown, New South Wales and 7 other locations | Recruiting | Jun 4, 2024 |
| Stopping somatostatin analogues after targeted radiotherapy for neuroendocrine tumors | Phase 2 | Sydney, New South Wales and 16 other locations | Recruiting | Apr 3, 2024 |
| Combination of chemotherapy, radiation, and immune therapy for esophageal cancer | Phase 2 | Garran, Australian Capital Territory and 8 other locations | Recruiting | Mar 4, 2024 |
All recruiting trials (4)
-
MRI-guided adaptive stereotactic radiotherapy for abdominal cancer
This study will try MRI-guided adaptive stereotactic radiotherapy (MRI-Linac SABR) to see if it improves local control, survival, and reduces side effects for adults with up to five abdominal oligometastatic lesions or primary liver cancer.
-
Combining Durvalumab and Olaparib for Advanced Cholangiocarcinoma Treatment
This study is testing if combining two drugs, durvalumab and olaparib, can help people with advanced cholangiocarcinoma feel better and live longer after their initial chemotherapy.
-
Stopping somatostatin analogues after targeted radiotherapy for neuroendocrine tumors
This study is testing whether stopping or continuing somatostatin analogues after starting a specific radiation therapy can help people with certain neuroendocrine tumors live longer without their cancer getting worse.
-
Combination of chemotherapy, radiation, and immune therapy for esophageal cancer
This study is testing a new treatment plan that combines chemotherapy, radiation, and an immune therapy to see if it helps people with advanced esophageal cancer feel better and live longer.
Quick answers
How many clinical trials run by Australasian Gastro-Intestinal Trials Group are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in Australia (4 trials), Canada (1 trial), New Zealand (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.